rs114216498

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003907.3(EIF2B5):​c.1686G>A​(p.Gln562Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00309 in 1,613,952 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 11 hom. )

Consequence

EIF2B5
NM_003907.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 5.69

Publications

5 publications found
Variant links:
Genes affected
EIF2B5 (HGNC:3261): (eukaryotic translation initiation factor 2B subunit epsilon) This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Nov 2009]
EIF2B5-DT (HGNC:55202): (EIF2B5 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 3-184143083-G-A is Benign according to our data. Variant chr3-184143083-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259195.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00217 (330/152346) while in subpopulation AMR AF = 0.00438 (67/15304). AF 95% confidence interval is 0.00354. There are 0 homozygotes in GnomAd4. There are 149 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2B5NM_003907.3 linkc.1686G>A p.Gln562Gln synonymous_variant Exon 12 of 16 ENST00000648915.2 NP_003898.2 Q13144
EIF2B5XM_011513265.1 linkc.936G>A p.Gln312Gln synonymous_variant Exon 8 of 12 XP_011511567.1
EIF2B5XM_011513266.4 linkc.849G>A p.Gln283Gln synonymous_variant Exon 7 of 11 XP_011511568.1
EIF2B5XM_047449148.1 linkc.*274G>A downstream_gene_variant XP_047305104.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2B5ENST00000648915.2 linkc.1686G>A p.Gln562Gln synonymous_variant Exon 12 of 16 NM_003907.3 ENSP00000497160.1 Q13144

Frequencies

GnomAD3 genomes
AF:
0.00217
AC:
330
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00438
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00307
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00215
AC:
539
AN:
250890
AF XY:
0.00207
show subpopulations
Gnomad AFR exome
AF:
0.000499
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00245
Gnomad NFE exome
AF:
0.00326
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00319
AC:
4656
AN:
1461606
Hom.:
11
Cov.:
32
AF XY:
0.00304
AC XY:
2210
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33466
American (AMR)
AF:
0.00280
AC:
125
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.000575
AC:
15
AN:
26100
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86192
European-Finnish (FIN)
AF:
0.00288
AC:
154
AN:
53416
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00376
AC:
4182
AN:
1111900
Other (OTH)
AF:
0.00220
AC:
133
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
274
548
821
1095
1369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00217
AC:
330
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.00200
AC XY:
149
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000529
AC:
22
AN:
41588
American (AMR)
AF:
0.00438
AC:
67
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00307
AC:
209
AN:
68030
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00235
Hom.:
0
Bravo
AF:
0.00245
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00278
EpiControl
AF:
0.00249

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EIF2B5: BP4 -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vanishing white matter disease Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Mar 08, 2021
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
6.1
DANN
Benign
0.76
PhyloP100
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114216498; hg19: chr3-183860871; API